Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial

OBJECTIVE: VIOLIN (TMC125IFD3002; NCT01422330) evaluated the safety, tolerability, and pharmacokinetics of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected patients. METHODS: In a 48-week, phase IV, single-arm, multicenter study, patients on prior antiretroviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Arathoon, Eduardo, Bhorat, Asad, Silaghi, Rodica, Crauwels, Herta, Lavreys, Ludo, Tambuyzer, Lotke, Van Baelen, Ben, Vanveggel, Simon, Opsomer, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367767/
https://www.ncbi.nlm.nih.gov/pubmed/28382208
http://dx.doi.org/10.1177/2050312116686482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367767/
https://www.ncbi.nlm.nih.gov/pubmed/28382208
http://dx.doi.org/10.1177/2050312116686482

Ejemplares similares